A tendency toward increased CD44v7 expression ( p = 0.052 ) was observed in patients who received neoadjuvant therapy compared with untreated patients, although this difference did not reach statistical significance.
← all excerpts
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma.
1
—
—